«Demyelinating Diseases

Below is an extended Demyelinating Diseases patents listing. Click here to return to the Demyelinating Diseases main in depth entry.

Patents :
US Patent No.	Title
7374761	Recombinant A2-specific TNF.alpha.-specific antibodies
7390637	Keratinocyte derived interferon
7390830	Remedies or prophylactics for diseases in association with chemokines
7390884	Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease
7392140	Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
7393532	Modulation of T cell differentiation for the treatment of T helper cell mediated diseases
7393662	Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
7393835	Peptide inhibitors of protein kinase C
7393852	Piperazine derivatives and methods of use
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7393942	Nucleic acids encoding mutant forms of Fas ligand
7388023	Amino acids with affinity for the .alpha.2.delta.-protein
7387993	Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-.alpha.inhibitors
7384965	Fused heterocyclic derivatives as PPAR modulators
7375133	Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
7378089	Gene therapy for the prevention of autoimmune disease
7378253	Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
7378492	CD40-related receptor that binds CD40L
7381722	Tetracyclic amino and carboxamido compounds and methods of use thereof
7381800	Antibodies to HBIMF63 polypeptide
7381809	Compositions and methods for the treatment of immune related diseases
7381826	Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
7384736	Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
7384915	Chimeric insulin-gad proteins for treating patients with type 1 diabetes or at risk of developing type 1 diabetes
7393955	Isoquinoline derivatives and methods of use thereof
7396659	Inhibitors of nitric oxide synthase to treat type 1 diabetes
7416885	Proliferated cell lines and uses thereof
7419663	Treatment of complement-associated disorders
7419799	Compositions and methods for the treatment of immune related diseases
7425330	Methods of inhibiting TNF.alpha. activity in the blood of a patient
7425332	Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
7425631	Compounds and methods of use
7427490	Diagnostic markers of stroke and cerebral injury and methods of use thereof
7427631	Metalloproteinase inhibitors
7429374	Process for the measurement of the potency of glatiramer acetate
7429560	Ketoamide inhibitors in chronic nerve disease
7416729	Methods of treating rheumatoid arthritis with anti-TNF antibodies
7414134	B1 bradykinin receptor antagonists
7414062	Triazaspiro compounds useful for treating or preventing pain
7396663	Isolated polynucleotide encoding a G-protein coupled receptor
7396850	Pyrazole derivative as PPAR modulator
7402303	Chemokine mutants in the treatment of multiple sclerosis
7404955	Methods of inhibiting or neutralizing TNF.alpha. in patients with tissue injury
7405212	Helix mimetics and composition and methods related thereto
7405279	Chimeric proteins for diagnosis and treatment of diabetes
7407952	Reverse-turn mimetics and compositions and methods related thereto
7407966	Thienopyridinone compounds and methods of treatment
7411051	Antibodies to HDPPA04 polypeptide
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7429618	Potassium channel modulators

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.